FDA NDC Directory · JSON-LD · Markdown

ORPHENADRINE CITRATE

NDC 43386-480 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerLupin Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA040284
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsORPHENADRINE CITRATE (100 mg/1)
Marketing started19980619
Package count3

External sources

Source: openFDA. Public-domain (CC0).